

Endocrine Surgery
Endocrinologist, physical trainer; Educator in diabetes, International Diabetes Federation, Sao Paulo, Brazil
Selected publications from PubMed
Impact of BRCA2 pathogenic variants on outcomes to first-line CDK4/6 inhibitors plus endocrine therapy in HR-positive/HER2-negative metastatic breast cancer.
Cruellas M, Rodriguez-Hernandez A, Carità L, Seguí E, Cejuela M, Lema L, García-Torralba E, Roqué-Lloveras A, Fernández-Ortega A, Melé M, Tapia M, Servitja S, González-Santiago S, Blaya-Boluda N, Bellet M, Martínez-Sáez O, Pimentel I, García-Fructuoso I, Pascual T, Joval-Ramentol L, Viñas G, Rey Aceituno M, Casas A, Castillo E, Brasó-Maristany F, Vivancos A, Serra V, Villacampa G, Oliveira M, Prat A, Saura C, Adamo B, Balmaña J
ESMO Open. 2026 Aug;11(8):108335 doi: 10.1016/j.esmoop.2026.108335.
Lactuca sativa L. losses and wastes as a source of biobased ingredients.
Rodrigues JP, da Silveira TF, Rodrigues DB, Domínguez L, Morales P, Pires TC, Oliveira MBP, Fernandes Â, Barros L
J Sci Food Agric. 2026 Apr;106(6):3577-3591 doi: 10.1002/jsfa.70450.
Addition of Ipatasertib to Dual Anti-HER2 Maintenance Therapy in HER2-Positive Metastatic Breast Tumors with PIK3CA Mutations: The Phase Ib SOLTI-1507 IPATHER Trial.
Oliveira M, Ciruelos E, Villacampa G, Morales S, Salvador Bofill J, Quiroga V, Gavilá J, Cortegoso A, Vega E, Henao F, Servitja S, Tolosa P, Chillara S, Bergamino M, Salvador F, Paes Dias M, Ferrero-Cafiero JM, Gonzalez Farre X, Pascual T, Saura C
Clin Cancer Res. 2026 Feb 4;32(3):468-478 doi: 10.1158/1078-0432.CCR-25-2298.
Risk factors for wildlife-transmitted diseases in communities engaged in wildlife consumption- A case study on neotropical echinococcosis.
Menajovsky MF, San José A, Oliveira MA, Campos-Silva J, Peña PP, Hernández-Guevara JE, Bosmediano J, Saldaña J, Del Moral Sachetti F, Meza-Sanchez G, Rodó X, Mayor P
Acta Trop. 2025 Aug;268:107701 doi: 10.1016/j.actatropica.2025.107701.
[Development of a prototype instrument to assess women's culinary autonomy].
Maldonado L, Oliveira MFB, Castro IRR
Cad Saude Publica. 2025;41(2):e00078924 doi: 10.1590/0102-311XPT078924.
Help your network discover Dr. Marcos Morales Oliveira's clinical expertise.